Authors: McCormack, S Tilzey, A Carmichael, A Gotch, F Kepple, J Newberry, A Jones, G Lister, S Beddows, S Cheingsong, R Rees, A Babiker, A Banatvala, J Bruck, C Darbyshire, J Tyrrell, D Van Hoecke, C Weber, J

Citation: S. Mccormack et al., A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120(W61D) derived from dual tropic R5X4 HIV-1(ACH320), VACCINE, 18(13), 2000, pp. 1166-1177